Boditech Med Inc. of Chuncheon-si, Gangwon-do at MEDICA 2018 in Düsseldorf -- MEDICA - World Forum for Medicine
Manufacturers

Boditech Med Inc.

43, Geodudanji 1-gil, Dongnae-myeon, 24398 Chuncheon-si, Gangwon-do
Korea, Republic
Telephone +82 33 2431400
Fax +82 33 2439373
ktw@boditech.co.kr

Hall map

MEDICA 2018 hall map (Hall 18): stand D09

Fairground map

MEDICA 2018 fairground map: Hall 18

Contact

Tae Won Kim

Our range of products

Product categories

Our products

Product category: Immuno assay testing

Point Of Care Test system - ichroma™ II

ichroma™ II is an automatic or semiautomatic in-vitro diagnostic device that measures the concentration of analytes, contained in blood, urine, or other samples, in quantitative or semi-quantitative ways. Compared to the first-generation device, ichroma™, ichroma™ II has an improved user interface and display and an advanced optical system, which provide the user with disease test options in the wide range.

More Less

Product category: Immuno assay testing

Point Of Care Test system - AFIAS-6

AFIAS-6 (AFIAS-automated fluorescent immunoassay system) is an automated fluorescent immunoassay system that uses blood, urine, and other samples to measure quantitatively or semi-quantitatively the concentration of a targeted analyte. AFIAS all-in-one cartridges are designed to optimize the structure and operating principle of the reader. Its automated test process enables to carry out multiple simultaneous tests for six different samples. For some specified items such as TSH, CRP, PCT and HbA1c, small volume (10uL or 50uL) of whole blood from a finger or heel can be used for quantitative testing using a C-tip (capillary tip).

More Less

Product category: Immuno assay testing

Point Of Care Test system - AFIAS-1

AFIAS-1 (AFIAS-automated fluorescent immunoassay system) is an automatic immunoassay system that measures the concentration of a targeted analyte in a sample, using quantitative or semi-quantitative methods using blood, urine, and other samples. The AFIAS-1 reader is easy to carry and has a simple structure. Also, AFIAS-1 uses all-in-one cartridges which automates the entire procedures from sample preparation to test when user loads sample only.
Since AFIAS-1 uses a single channel, it is optimized for small and mid-sized hospitals (or clinics) testing up to 10 samples per hour. For some tests, such as TSH, CRP, PCT, and HbA1c, a quantitative test can be performed using a small sample (10uL or 50uL) of whole blood from a finger or heel using an applicable C-tip (capillary tip).

More Less

Product category: Immuno assay testing

hemochroma PLUS

hemochroma PLUS is an in vitro diagnostic device dedicated to quantitative testing of total hemoglobin concentration in the blood. It is lightweight with small dimensions and battery operated. It is easy to operate and convenient. It provides accurate and reliable inspection results compared with large analyzers.

More Less

Product category: Immuno assay testing

Test items for immunoassay

These tests are used for disease test for heart disease, cancer, diabetes, infectious diseases and hormonal disorders related to lifestyle. In 2012, Boditech Med. succeeded in testing the world's first TSH and hCG tests using whole blood. All ichroma ™ tests are CE-certified. ichroma ™ readers and CRP tests are FDA approved.

More Less

Product category: Immuno assay testing

ichroma PCT

Identifying sepsis is a daily challenge in the intensive care unit of every hospital. Early assessment of sepsis is vital for determination of the appropriate treatment since various therapeutic strategies are known to improve survival of patients with sepsis.
In healthy people, the concentration of plasma PCT is below 0.1 ng/mL. The level of PCT rises rapidly after a bacterial infection with systemic consequences. It can also be elevated by other situation such as major surgery, severe burns, or in neonates. However, it returns to baseline rapidly. Viral infections, bacterial colonization, localized infections, allergic disorders, autoimmune diseases, and transplant rejection do not usually induce a significant PCT response (values <0.5 ng/mL). Therefore, by evaluating PCT concentrations, the physicians are able to engage in the risk assessment for progression to severe sepsis and septic shock.

More Less

Product category: Immuno assay testing

ichroma Vitamin D

Vitamin D from the diet or dermal synthesis from sunlight is biologically inactive and is a fat soluble steroid hormone involved in the active intestinal absorption of calcium and in the regulation of its homeostasis. In humans, the most important compounds in this group are vitamin D3 (also known as cholecalciferol) and vitamin D2 (ergocalciferol).[1] In the liver, cholecalciferol (vitamin D3) is converted to calcidiol, 25-hydroxycholecalciferol (abbreviated 25(OH)D3). Ergocalciferol (vitamin D2) is converted in the liver to 25- hydroxyergocalciferol (25(OH)D2). It is widely known that circulating 25(OH)D is the best indicator of vitamin D status.[2,3] 25(OH)D3 is then converted in the kidneys (by the enzyme 25(OH)D-a-hydroxylase) into 1,25-(OH)2D3, a steroid hormone that is the active form of vitamin D. It can also be converted into 24-hydroxycalcidiol in the kidneys via 24-hydroxylation.[4,5]
1,25-(OH)2D3 circulates as a hormone in the blood, regulating the concentration of calcium and phosphate in the bloodstream and promoting the healthy growth and remodeling of bone. 1,25-(OH)2D3 also affects neuromuscular and immune function.[6] Vitamin D has a significant role in calcium homeostasis and metabolism. Its discovery was due to effort to find the dietary substance lacking in rickets (the childhood form of osteomalacia).[7]
This test can be used to diagnose vitamin D deficiency, and it is indicated in patients with high risk for vitamin D deficiency and when the results of the test would be used as supporting evidence for beginning aggressive therapies.[8] Patients with osteoporosis, chronic kidney disease, malabsorption, obesity, and some other infections may be high risk and thus have greater indication for this test.[9,10]

More Less

Company news

Date

Topic

Download

Aug 1, 2018

Now available - Gastrointestinal diagnosis tests


Boditech is proud to announce the launching of gastrointestinal diagnosis tests: iFOB Neo, Calprotectin and iFOB/Calp. Combo. These 3 products are available on ichroma analyzers: ichroma, ichorma II and ichroma-50. All components of these new products can be stored at room temperature conveniently.

The NEW, ichroma iFOB Neo
The ichorma iFOB Neo is much improved in terms of performance and user-friendliness than previous iFOB with improved stability and reproduciblity. 
And sample collection tubes changed to easy to use. Since new ichroma iFOB Neo is 100% compatible with current ichroma analyzers, previous ichroma iFOB is going to be discontinued and replaced to ichroma iFOB Neo.

True POCT - ichroma Calprotectin
Calprotectin is a protein released by neutrophils a type of white blood cells. When there is inflammation in gastrointestinal (GI) tract, neutrophils move to GI tract and release calprotectin, resulting in an increased level in the stool. ichroma Calprotectin can be used for diagnosis and monitoring of inflammatory bowel disease patients. And ichroma Calprotectin test is a useful tool to distinguish inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS). ichroma Calprotectin is quantitative point of care test which is easy, fast and cost-effective.
 
COST and TIME EFFICIENCY, ichroma iFOB/Calp. Combo
ichroma iFOB/Calp. Combo is the first test of this kind combining iFOB for colorectal cancer screening and calprotectin for the diagnosis of inflammatory bowel disease (IBD).

By combining iFOB and Calprotectin, it helps physicians to suggest additional screening and treatment to patients with bowel symptoms in primary health care settings. ichroma iFOB/Calp. combo can be a good 'rule-out' test for significant bowel disease. Boditech offers ichroma iFOB/Calp. Combo at the same price as the ichroma Calprotectin until this September commemorating the launch. 
to use these new products, you must upgrade the software on your ichroma analyzer.

More Less

About us

Company details

Boditech Med Inc. has been developing products for in-vitro diagnostics and diagnostic reagents for the past 20 years by pursuing the value of a company called "Respect for Life".
In particular, about 25,000 units of ichroma ™ readers are installed and operated world wide, and ichroma™ CRP (C-Reactive Protein) has secured its largest market share in China, showing a unique competitiveness.
Boditech Med Inc. is leading the way in exploring new markets through the automation of on-site diagnosed immunodiagnostic devices and the development of new high-sensitive diagnostic reagents. We have built up our reputation successfully by carrying out various national R & D projects based on solid technology, experience, and human resources accumulated over the years.
In addition, Boditech Med Inc. is developing a smart production system that integrates digital technology and IT technology to flexibly manage the production scale. All employees of Boditech Med Inc. is making every effort with pride that we are the top leader of BT-IT convergence industry in Korea.

More Less

Company data

Number of employees

100-499

Foundation

1998

Area of business

Diagnostics